BioCardia, Inc. reported that as of September 24, 2025, it has regained compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million, through various financing transactions raising approximately $5.1 million and $1.0 million from stock sales. This filing serves as an update following a previous notification on April 1, 2025, regarding non-compliance.